Saxenda (liraglutide)
Saxenda is a daily injection product containing liraglutide, made by Novo Nordisk. Its approved use in the U.S. is weight management.
Educational information. This page does not give dosing instructions or tell you what to take. The current label and a prescriber decide that.
What Saxenda is
- Generic name
- Liraglutide
- Maker
- Novo Nordisk
- Form
- Daily injection
- U.S. approved use
- Weight management
- First U.S. approval
- 2014
How it differs from related products
Saxenda and Victoza both contain liraglutide as a daily injection, but they are separate products with different approved uses. Saxenda is approved for weight management. Victoza is approved for type 2 diabetes.
| Product | Form | U.S. approved use | Status |
|---|---|---|---|
| Saxenda (this page) | Daily injection | Weight management | FDA-approved for weight management |
| Victoza | Daily injection | Type 2 diabetes | FDA-approved, but not for obesity |
What it is approved for
- Weight management in adults with obesity, or overweight plus at least one weight-related condition
- Weight management in children 12 and older who weigh more than 60 kg and have obesity
How it is taken
Daily injection under the skin from a prefilled pen. Follow the label and your prescriber for how to use it.
What the trials found
No trial figures have been added to this atlas for Saxenda yet.
Safety
Warnings, side effects and open questions for liraglutide are on the liraglutide page. The official label is the controlling source.
Compiled from public information: FDA-approved labels, manufacturer websites, ClinicalTrials.gov and published journal articles. Sources are listed at the bottom of this page.
Related
Sources
- Saxenda (liraglutide) injection: prescribing information Novo Nordisk, on DailyMed (U.S. National Library of Medicine). Label version 6/2026. Official FDA label on DailyMed
- DailyMed: current FDA drug labels U.S. National Library of Medicine. Regulator
- Drugs@FDA: approved drug products U.S. Food and Drug Administration. Regulator